Concepedia

A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial

Gerd Hasenfuß, Chris Hayward, Daniel Burkhoff, Frank E. Silvestry, S. McKenzie, Finn Gustafsson, Filip Málek, Jan Van der Heyden, Iréne Lang, Mark C. Petrie,

The Lancet · 2016 · 289 citations · 25 references

DOIFull text

Open access

Concepts

References

25

Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction

Theophilus Owan, David O. Hodge, Regina M. Herges et al. · New England Journal of Medicine · 2006 · 4.2K citations

, , +14

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

Salim Yusuf, Marc A. Pfeffer, Karl Swedberg et al. · The Lancet · 2003 · 3K citations

, , +12

Spironolactone for Heart Failure with Preserved Ejection Fraction

Bertram Pitt, Marc A. Pfeffer, Susan F. Assmann et al. · New England Journal of Medicine · 2014 · 2.7K citations · Full text

, , +16

How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology

Walter J. Paulus, Carsten Tschöpe, John E. Sanderson et al. · European Heart Journal · 2007 · 2.7K citations · Full text

, , +17

Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction

Barry M. Massie, Peter E. Carson, John J.V. McMurray et al. · New England Journal of Medicine · 2008 · 1.9K citations · Full text

, , +12